Variants in the TBX4 gene were identified as potential genetic causes of PAH in a subset of Japanese patients, disrupting its regulation of fibroblast growth factor (FGF) 10 and leading to insufficient lung morphogenesis. The gene discussed is TBX4; the disease is pulmonary arterial hypertension.